Endocrinology Archives

Videos

Reducing cardiovascular death with SGLT2 inhibitors – Important updates for GPs

Prof Andrew Sindone and Dr Ted Wu discuss the importance of SGLT2 inhibitors and the ground-breaking evidence that has seen this class of drugs now be recommended as second-line T2D treatment

Videos

Clinical Case: 36-year-old female with obesity

In this Quick Case Endocrinologist A/Prof Samantha Hocking presents the obesity management case of a 36-year-old female, describes treatment options, clinical outcomes, and provides some take home messages.

Videos

Tirzepatide injection update & practical demonstration

In this Product Explainer, Endocrinologist A/Prof Samantha Hocking provides an update on tirzepatide injection for chronic weight management and provides a detailed demonstration of how to use the device.

Podcasts

Using SGLT2 to reduce cardiovascular death in T2D – Important updates for GPs

Professor Andrew Sindone and Dr Ted Wu discuss the importance of SGLT2 inhibitors for patients with type 2 diabetes and cardiovascular disease.

Clinical Articles

Endometriosis update: new drugs, diagnostics, subsidies & guidelines coming

Parallel advances promise significant improvements

Podcasts

Preventing renal failure in type 2 diabetes – New options

Dr Bobby Chan presents the new therapeutic option for diabetes-related chronic kidney disease.

Clinical Articles

Lipoedema: Mythbusting a mysterious condition

The psychological impact can be massive - experts advise on how to detect and manage to reduce its harms...

Podcasts

Semaglutide: Which dose for which patient Part 1: Your questions answered

Expert A/Prof Ralph Audehm answers questions submitted by Australian GPs and healthcare professionals on the topic of Semaglutide.

Podcasts

Expert Panel: Pharmacotherapy for weight management

Our expert panel, facilitated by A/Prof Ralph Audehm and panelists A/Prof Samantha Hocking and Prof John Dixon, discusses pharmacotherapy for weight management, including options available, GLP-1s and setting realistic weight goals.

Videos

Contrave (naltrexone hydrochloride / bupropion hydrochloride) tablets in weight management

In this Product Explainer, Endocrinologist A/Prof Sarah Glastras explains the role of Contrave (naltrexone hydrochloride / bupropion hydrochloride) tablets as an adjunct to a reduced-calorie diet and increased physical activity, for the management of weight in adult patients ≥ 30 kg/m2 (obese), or ≥ 27 kg/m² to < 30 kg/m2 (overweight) in the presence of one or more weight-related comorbidities.

Videos

Tirzepatide for chronic weight management

In this Product Explainer, Endocrinologist A/Prof Samantha Hocking explains the role of tirzepatide injection for chronic weight management (CWM) and how to use the device.

Podcasts

Weight loss maintenance – Lecture

A/Prof Samantha Hocking details why maintaining weight loss is so problematic.

Endocrinology

Reducing cardiovascular death with SGLT2 inhibitors – Important updates for GPs

Prof Andrew Sindone and Dr Ted Wu discuss the importance of SGLT2 inhibitors and the ground-breaking evidence that has seen this class of drugs now be recommended as second-line T2D treatment

Clinical Case: 36-year-old female with obesity

In this Quick Case Endocrinologist A/Prof Samantha Hocking presents the obesity management case of a 36-year-old female, describes treatment options, clinical outcomes, and provides some take home messages.

Tirzepatide injection update & practical demonstration

In this Product Explainer, Endocrinologist A/Prof Samantha Hocking provides an update on tirzepatide injection for chronic weight management and provides a detailed demonstration of how to use the device.

Using SGLT2 to reduce cardiovascular death in T2D – Important updates for GPs

Professor Andrew Sindone and Dr Ted Wu discuss the importance of SGLT2 inhibitors for patients with type 2 diabetes and cardiovascular disease.

Endometriosis update: new drugs, diagnostics, subsidies & guidelines coming

Parallel advances promise significant improvements

Preventing renal failure in type 2 diabetes – New options

Dr Bobby Chan presents the new therapeutic option for diabetes-related chronic kidney disease.

Lipoedema: Mythbusting a mysterious condition

The psychological impact can be massive - experts advise on how to detect and manage to reduce its harms...

Semaglutide: Which dose for which patient Part 1: Your questions answered

Expert A/Prof Ralph Audehm answers questions submitted by Australian GPs and healthcare professionals on the topic of Semaglutide.

Expert Panel: Pharmacotherapy for weight management

Our expert panel, facilitated by A/Prof Ralph Audehm and panelists A/Prof Samantha Hocking and Prof John Dixon, discusses pharmacotherapy for weight management, including options available, GLP-1s and setting realistic weight goals.

Contrave (naltrexone hydrochloride / bupropion hydrochloride) tablets in weight management

Tirzepatide for chronic weight management

In this Product Explainer, Endocrinologist A/Prof Samantha Hocking explains the role of tirzepatide injection for chronic weight management (CWM) and how to use the device.

Weight loss maintenance – Lecture

A/Prof Samantha Hocking details why maintaining weight loss is so problematic.

Get the app

Site

Company

Connect

Legal

Healthed

Endocrinology

Prof Andrew Sindone and Dr Ted Wu discuss the importance of SGLT2 inhibitors and the ground-breaking evidence that has seen this class of drugs now be recommended as second-line T2D treatment

In this Quick Case Endocrinologist A/Prof Samantha Hocking presents the obesity management case of a 36-year-old female, describes treatment options, clinical outcomes, and provides some take home messages.

In this Product Explainer, Endocrinologist A/Prof Samantha Hocking provides an update on tirzepatide injection for chronic weight management and provides a detailed demonstration of how to use the device.

Professor Andrew Sindone and Dr Ted Wu discuss the importance of SGLT2 inhibitors for patients with type 2 diabetes and cardiovascular disease.

Parallel advances promise significant improvements

Dr Bobby Chan presents the new therapeutic option for diabetes-related chronic kidney disease.

The psychological impact can be massive - experts advise on how to detect and manage to reduce its harms...

Expert A/Prof Ralph Audehm answers questions submitted by Australian GPs and healthcare professionals on the topic of Semaglutide.

Our expert panel, facilitated by A/Prof Ralph Audehm and panelists A/Prof Samantha Hocking and Prof John Dixon, discusses pharmacotherapy for weight management, including options available, GLP-1s and setting realistic weight goals.

In this Product Explainer, Endocrinologist A/Prof Samantha Hocking explains the role of tirzepatide injection for chronic weight management (CWM) and how to use the device.

A/Prof Samantha Hocking details why maintaining weight loss is so problematic.

Get the app

Site

Company

Connect

Legal

Already a member? Log in for full access

Don't have an existing account? Sign up today

Extra Details

Healthed